In Vitro Metabolism of Artepillin C by Rat and Human Liver Microsomes

Abstract

Artepillin C, a natural product present in the Brazilian green propolis, has several biological properties. Among these properties, the antitumor action of this product is noteworthy and makes it a promising drug candidate for the treatment of several types of cancer. This paper describes the in vitro metabolism of Artepillin C in rat and human liver microsomes. The rat model suggested a sigmoidal profile for the metabolism, adapted to the Hillʼs kinetic model. The enzymatic kinetic parameters were as follows: maximal velocity = 0.757 ± 0.021 µmol/mg protein/min, Hill coefficient = 10.90 ± 2.80, and substrate concentration at which half-maximal velocity of a Hill enzyme is achieved = 33.35 ± 0.55 µM. Based on these results, the calculated in vitro intrinsic clearance for Artepillin C was 16.63 ± 1.52 µL/min/mg protein. The in vitro metabolism assay conducted on the human model did not fit any enzymatic kinetic model. Two novel metabolites were formed in both mammal microsomal models and their chemical structures were elucidated for the first time. The main human cytochrome P450 isoforms involved in Artepillin C metabolism had been identified, and the results suggest a majority contribution of CYP2E1 and CYP2C9 in the formation of the two metabolites.

Key words

Artepillin C - enzymatic kinetics - liver microsomes - natural product - in vitro metabolism

• References

• 1 Figueiredo FJB, Dias-Souza MV, Nascimento EA, de Lima LRP. Physicochemical characterization and flavonoid contents of artisanal Brazilian green propolis. Int J Pharm Sci 2015; 7: 64-68
• 2 Barth OM, de Freitas AS, Matsuda AH, de Almeira-Muradian LB. Botanical origin and Artepillin-C content of Brazilian propolis samples. Grana 2013; 52: 129-135
• 3 Szliszka E, Kucharska AZ, Sokól-Letowska A, Mertas A, Czuba ZP, Krol W. Chemical composition and anti-inflammatory effect of ethanolic extract of Brazilian green propolis on activated J774A.1 macrophages. Evid Based Complement Alternat Med 2013; 2013: 976415
• 4 Choi S, Cha B, Iida K, Lee Y, Yonezara T, Teruya T, Nagai K, Woo J. Artepillin C, as a PPARγ ligand, enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Biochem Pharmacol 2011; 81: 925-933
• 5 Hori JI, Zamboni DS, Carrão DB, Goldman GH, Berretta AA. The inhibition of inflammasome by Brazilian propolis (EPP-AF). Evid Based Complement Alternat Med 2013; 2013: 418508
• 6 Aga H, Shibuya T, Sugimoyo T, Kurimoto M, Nakajima S. Isolation and identification of antimicrobial compounds in Brazilian propolis. Biosci Biotechnol Biochem 1994; 58: 945-946
• 7 Shimizu K, Ashida H, Matsuura Y, Kanazawa K. Antioxidative bioavailability of Artepillin C in Brazilian propolis. Arch Biochem Biophys 2004; 424: 181-188
• 8 Kimoto T, Arai S, Aga M, Hanaya T, Kohguchi M, Nomura Y, Kurimoto M. Cell cycle and apoptosis in cancer induced by Artepillin C extracted from Brazilian propolis. Gan To Kagaku Ryoho 1996; 23: 1855-1859
• 9 Kimoto T, Koya-Miyata S, Hino K, Micallef MJ, Hanaya T, Arai S, Ikeda M, Kurimoyo M. Pulmonary carcinogenesis induced by ferric nitriloacetate in mice and protection from it by Brazilian propolis and Artepelin C. Virchows Arch 2001; 438: 259-270
• 10 Shimizu K, Das SK, Baba M, Matsuura Y, Kanazawa K. Dietary Artepillin C suppresses the formation of aberrant crypt foci induced by azoxymethane in mouse colon. Cancer Lett 2006; 240: 135-142
• 11 Szliszka E, Zydowicz G, Mizgala E, Krol W. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) sensitizes LNCaP prostate cancer cells to TRAIL-induce apoptosis. Int J Oncol 2012; 41: 818-828
• 12 Kimoto T, Aga M, Hino K, Koya S, Yamamoto Y, Hanaya T, Arai S, Ikeda M, Kurimoto M. Apoptosis of human leukemia cell lines induced by Artepillin C extracted from Brazilian propolis. Biother 1998; 12: 1135-1142
• 13 Zhang A, Sun H, Wang X. Recent advances in natural products from plants for treatment of liver diseases. Eur J Med Chem 2013; 63: 570-577
• 14 Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005; 4: 206-220
• 15 Asha S, Vidyavathi M. Role of human liver microsomes in in vitro metabolism of drugs – a review. Appl Biochem Biotech 2010; 160: 1699-1722
• 16 Fasinu P, Bouic PJ, Rosenkranz B. Liver-base in vitro technologies for drug biotransformations studies – a review. Curr Drug Metab 2012; 13: 215-224
• 17 Stepan AF, Mascitii V, Beaumont K, Kalgutkar AS. Metabolism-guided drug design. MedChemComm 2013; 4: 631-652
• 18 Hutzler JM, Tracy TS. Atypical kinetic profiles in drug metabolism reactions. Drug Metab Dispos 2002; 30: 355-362
• 19 Tracy TS. Atypical cytochrome p450 kinetics: implications for drug discovery. Drugs R D 2006; 7: 349-363
• 20 Seibert E, Tracy TS. Fundamentals of Enzyme Kinetics. In: Nagar S, Argikar UA, Tweedie DJ. eds. Enzyme Kinetics in Drug Discovery. Hatfield: Springer Protocols; 2014: 9-22
• 21 Moreira FL, Souza GHB, Rodrigues IV, Lopes NP, de Oliveira AR. A non-michaelian behavior of the in vitro metabolism of the pentacyclic triterpene alfa and beta amyrins by employing rat liver microsomes. J Pharm Biomed Anal 2013; 84: 14-19
• 22 Marques LMM, da Silva Jr. EA, Gouvea DR, Vessecchi R, Pupo MT, Lopes NP, Kato MJ, de Oliveira AR. In vitro metabolism of the alkaloid piplartine by rat liver microsomes. J Pharm Biomed Anal 2014; 95: 113-120
• 23 Guideline on Bioanalytical Method Validation – European Medicines Agency. Available at http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf Accessed May 5, 2016
• 24 Houston JB, Galentin A. Progress towards predictions of human pharmacokinetics parameters from in vitro technologies. Drug Metab Rev 2003; 35: 393-415
• 25 Naramoto K, Karo M, Ichihara K. Effects of an ethanol extract of Brazilian green propolis on human cytochrome P450 enzyme activities in vitro . J Agr Food Chem 2014; 62: 11296-11302
• 26 Jia L, Liu X. The conduct of drug metabolism studies considering good practice (II): in vitro experiments. Curr Drug Metab 2007; 8: 822-829
• 27 Nishimuta H, Nakagawa T, Noruma N, Yabuki M. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans, rats or dogs. Xenobiotica 2013; 43: 948-955
• 28 Li S, Teng L, Liu W, Cheng X, Jiang B, Wang Z, Wang C. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes. Drug Test Anal 2016;
• 29 Abass K, Reponen P, Mattila S, Rautio A, Pelkonen O. Comparative metabolism of benfuracarb in in vitro mammalian hepatic microsomes model and its implications for chemical risk assessment. Toxicol Lett 2014; 224: 290-299
• 30 Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006; 2: 875-894
• 31 Tolonen A, Turpeinen M, Pelkonen O. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov Today 2009; 14: 120-133
• 32 McLafertty FW, Tureek F. Interpretation of Mass Spectra. Sausalito: University Science Books; 1993: 371
• 33 Gonella NC. LC-RMN: expanding the limits of structure elucidation. Chromatography science series. Boca Raton: CRC Press; 2013: 301
• 34 Nirogi R, Palacharla RC, Uthukam V, Manoharan A, Srikakolapu SR, Kalaikadhiban I, Boggavarapu RK, Ponnamaneni RK, Ajjala DR, Bhyrapuneni G. Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays. Xenobiotica 2015; 45: 95-106
• 35 Bogaards JJP, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, Van Bladeren PJ, Walther B. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 2000; 30: 1131-1152
• 36 Almeida AM, Castel-Branco MM, Falcão AC. Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods. J Chromatogr B 2002; 774: 215-222
• 37 Hua X, Peng X, Tan S, Li C, Wang W, Luo M, Fu Y, Zu Y, Smyth H. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies. J Agric Food Chem 2014; 62: 10604-10614